Kangmei Pharma | 600518 - Cash And Equivalent

Stock Price
1.91
Daily Change
-0.02 -1.04%
Monthly
-1.04%
Yearly
-12.79%
Q1 Forecast
1.85

Kangmei Pharma reported CNY1.18B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Akebia Therapeutics USD 184.84M 18.4M Dec/2025
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Avita Medical AUD 12.22M 1.83M Jun/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Genomma Lab Internacional MXN 2.27B 250.5M Sep/2025
Hypermarcas BRL 1.86B 660.14M Sep/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Jiangsu Hengrui CNY 40.36B 4.24B Sep/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Moderna USD 2.6B 1.46B Dec/2025
Organon & Co USD 672M 73M Sep/2025
Revvity USD 919.86M 11.53M Dec/2025
Sh Fosun Pharma CNY 11.48B 1.48B Sep/2025
Tectonic Therapeutic USD 268.44M 18.94M Sep/2025
Viatris USD 1.32B 347.1M Dec/2025
Wuxi Apptec CNY 29.44B 7.95B Sep/2025
Xeris Pharmaceuticals USD 91.6M 32.32M Sep/2025
Zz Pientze Pharmaceu CNY 1.77B 376.03M Jun/2025